Fecal microbiota transplantation as a treatment option for patients with recurrent Clostridioides difficile-associated diarrhea
This paper provides a review of the largest studies (over the period of 2017 to 2022) on the use of fecal microbiota transplantation (FMT) for the treatment of patients with recurrent Clostridioides difficileassociated diarrhea (CDAD), including pseudomembranous colitis. A focus was made on methods...
Main Author: | Ortenberg E.A. |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy
2022-12-01
|
Series: | Клиническая микробиология и антимикробная химиотерапия |
Subjects: | |
Online Access: | https://cmac-journal.ru/publication/2022/4/cmac-2022-t24-n4-p308/cmac-2022-t24-n4-p308.pdf |
Similar Items
-
Development of an Open‐Access and Explainable Machine Learning Prediction System to Assess the Mortality and Recurrence Risk Factors of Clostridioides Difficile Infection Patients
by: Yui-Lun Ng, et al.
Published: (2021-01-01) -
Microbiota in <i>Clostridioides difficile</i>-Associated Diarrhea: Comparison in Recurrent and Non-Recurrent Infections
by: Alessandra Gazzola, et al.
Published: (2020-09-01) -
Pseudomembranes on colostomy in a patient with recurrent Clostridioides difficile infection
by: Hideki Ueda, et al.
Published: (2023-01-01) -
Antibiotic associated diarrhea due to Clostridioides difficile in a tertiary care teaching hospital, central India
by: Sunandini Kapoor, et al.
Published: (2023-02-01) -
Fecal Microbiota of Toxigenic Clostridioides difficile-Associated Diarrhea
by: Marta Hernández, et al.
Published: (2019-01-01)